| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -8.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ATOS returned -77.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -70.5% |
| 1 year | -77.7% |
| 5 years | -95.4% |
| 10 years | -99.4% |
| All-time high | $23,625.00 (Mar 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ATOS would be worth today ›No. Atossa Therapeutics, Inc. has not paid a dividend in the past 12 months.
Atossa Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ATOS.
Atossa Therapeutics, Inc. is part of the Healthcare sector.
Atossa Therapeutics, Inc. has a market cap of 26.03M USD, based on the latest quote.
